Differences in number and size observed between NSCLC and HS were unaltered during therapy (Figure 3A). Upon therapy CD9, CD81 and CD63 expression increased in both R and NR EVs (Figure 3B and Supplementary Figure 3A), hinting a possible influence of therapy on EVs origin. Here, CD63 is linked to non-small cell lung carcinoma.